Summary
Tumor progression is a relatively indolent process, with many years commonly intervening between the inception of an initiating genetic lesion and the development of overt malignant disease. We suggest that the perturbation of normal epithelial-mesenchymal interactions caused by the inappropriate presence of fibroblast subpopulations displaying various ‘fetal-like’ phenotypic characteristics may significantly alter the kinetics of tumor progression and hence enhance susceptibility to cancer development. In this communication, we review our own data indicating the presence of fetal-like fibroblasts in cancer patients and put these observations in the context of similar published reports. We then discuss our interpretation of these findings, emphasising the possible direct involvement of fetal-like fibroblasts in cancer pathogenesis and putting forward an epigenetic ‘clonal modulation’ model to account for their presence in cancer patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Azzarone, B., Marell, M., Billard, C., Scemana, P., Chaponnier, C. and Marciera-Coelho, M. (1984) Abnormal properties of skin fibroblasts from patients with breast cancer. Int. J. Cancer 33: 759–764.
Bartal, A.H., Lichtig, C., Cardo, C.C., Feit, C., Robinson, E. and Hirshaut, Y. (1986) Monoclonal antibody defining fibroblasts appearing in fetal and neoplastic tissue. J. Natl. Cancer Inst. 76: 415–419.
Basset, P., Bellocq, J.P., Wolf, C., Stoll, I., Hutin, P., Limacher, J.M., Podhajcer, O.L., Chenard, M.P., Rio, M.C. and Chambon, P. (1990) A novel metalloproteinase gene specifically expresed in stromal cells of breast carcinomas. Nature 348: 699–704.
Bayreuther, K., Rodemann, H.P., Hommel, R., Dittman, K., Albiez, M. and Francz, P.I. (1988) Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc. Natl. Acad. Sci. USA 85: 5112–5116.
Birchmeier, W., Behrens, J., Weidner, K.M., Frixen, U.H. and Schipper, J. (1991) Dominant and recessive genes involved in tumor cell invasion. Curr. Opin. Cell Biol. 3: 832–840.
Camps, J.L., Chang, S.M., Hsu, T.C., Freeman, M.R., Hong, S.J., Zhau, H.E., von Eschenbach, A.C. and Chung, L.W. (1990) Fibroblast-mediated acceleration of human epithelial tumor-growth in vitro. Proc. Natl. Acad. Sci USA 87: 75–79.
Chen, J., Grant, M.E., Schor, A.M. and Schor, S.L. (1989) Differences between adult and foetal fibroblasts in the regulation of hyaluronate synthesis: correlation with migratory activity. J. Cell Sci. 94: 577–589.
Chiquet-Ehrismann, R., Mackie, E.J., Pearson, C.A. and Sakaura, T. (1986) Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47: 131–139.
Cornil, I., Theodorescu, D., Man, S., Herlyn, M., Jambrosic, J. and Kerbel, R. S. (1991) Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl. Acad. Sci. USA 88: 6028–6032.
Crissman, J.D., Sakr, W.A., Hussein, M.E. and Pontes, J.E. (1993) DNA quantification of intraepithelial neoplasia and invasive carcinoma of the prostate. Prostate 22: 155–162.
Cullen, K.J., Smith, H.S., Hill, S., Rosen, N. and Lippman, M.E. (1991) Growth factor messenger RNA expression by human fibroblasts from benign and malignant lesions. Cancer Res. 51: 4978–4985.
Cunha, G.R., Bigsby, R.M., Cooke, P.S. and Sugimara, Y. (1985) Stromal-epithelial interactions in adult organs. Cell Diff. 17: 137–148.
Dabbous, M.K., Haney, L., Carter, L.M., Paul, A.K. and Reger, J. (1987) Heterogeneity of fibroblast response in host-tumor cell-cell interactions in metastatic tumors. J. Cell. Biochem. 35: 333–344.
Danes, B.S., De Angeles, P., Traganos, F., Ringborg, U., Nielsen, L.H. and Melamed, M.R. (1990) Comparison of anatomical location of squamous cell carcinoma within the oral cavity and oropharynx with the incidence of in vitro hyperdiploidly. Clin. Genet. 37: 188–193.
Docherty, R., Forrester, J.V., Lackie, J.M. and Gregory, D.W. (1989) Glycosaminoglycans facilitate the movement of fibroblasts through 3D collagen matrices. J. Cell Sci. 92: 263–267.
Durning, P., Schor, S.L. and Sellwood, R.A.S. (1984) Fibroblasts from patients with breast cancer show abnormal migratory behavior in vitro. Lancet ii: 890–892.
Dvorak, H.F. (1986) Tumors: wounds that do not heal. New Eng. J. Med. 315: 1650–1659.
Edward, M., Grant, A.W. and Mackie, R.M. (1992) Human melanoma cell-derived factor(s) stimulate fibroblast glycosaminoglycan synthesis. Int. J. Cancer 52: 499–503.
Ellis, I., Grey, A.M., Schor, A.M. and Schor, S.L. (1992) Antagonistic effects of transforming growth factor beta and MSF on fibroblast migration and hyaluronic acid synthesis: possible implications for dermal wound healing. J. Cell. Sci. 102: 447–456.
Elstad, C.A. and Hosick, H.L. (1987) Contribution of the extracellular matrix to the growth properties of cells from a preneoplastic outgrowth: possible role of hyaluronic acid. Exp. Cell Res. 55: 313–321.
Fabra, A., Nakajima, M., Bucana, C.D. and Fidler, I.J. (1992) Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. Differentiation 52: 101–110.
Feinberg, R.N. and Beebe, D.C. (1983) Hyaluronate in vasculogenesis. Science 220: 1177–1179.
Foulds, L. (1975) Neoplastic Development, Vol. 2. Academic Press, London.
Garin-Chesa, P., Old., L.J. and Retting, W.J. (1990) Cell surface glycoprotein of reactive stromal fibroblasts as a potential target in human epithelial cancers. Proc. Natl. Acad. Sci. USA 87: 7235–7239.
Gärtner, M.F.R.M., Wilson, E.L. and Dowdle, E.B. (1992) Fibroblast-dependent tumori-genicity of melanoma xenografts in athymic mice. Int. J. Cancer 51: 788–791.
Gleave, M., Hsieh, J.-T., Gao, C., von Eschenbach, A.C. and Chung, W.K. (1991) Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res. 51: 3573–3761.
Grey, A.M., Schor, A.M., Rushton, G., Ellis, I. and Schor, S.L. (1989) Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc. Natl. Acad. Sci. USA 86: 2438–2442.
Haggie, J., Schor, S.L., Howell, A., Birch, J.M. and Sellwood, R.A.S. (1987) Fibroblasts from relatives of hereditary breast cancer display foetal-like behaviour in vitro. Lancet i: 1455–1457.
Hay, E. (1993) Extracellular matrix alters epithelial differentiation. Curr. Op. Cell Biol. 5: 1029–1035.
Helin, K. and Harlow, E. (1993) The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 3: 43–46.
Irwin, C.R., Picardo, M., Ellis, I., Sloan, P., Grey, A.M., McGurk, M. and Schor, S.L. (1994) Inter-and intrasite heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing. J. Cell Sci. 107: 1333–1346.
Knudson, A.G. (1977) Genetics and etiology of human cancer. Adv. Hum. Genet. 8: 1–66.
Knudson, W., Biswas, C., Li, X.-Q., Nemec, R.E. and Toole, B.P. (1989) The role and regulation of tumor-associated hyaluronanh. In: The Biology of Hyaluronan. Ciba Foundation Symposium 143. John Wiley and Sons, Chichester, pp 150–159.
Lu, C., Vickers, M.F. and Kerbel, R.S. (1992) Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc. Natl. Acad. Sic. USA 89: 9215–9219.
Lynch, H.T., Albano, W.A., Heieck, J.J., Mulcahy, G.M., Lynch, J.F., Layton, M.A. and Danes, B.S. (1984) Genetics, biomarkers and control of breast cancer: a review. Cancer Genet. Cytogenet. 13: 43–92.
Markwald, R.R., Fitzharris, T.P., Bank, H. and Bernanke, D.H. (1978) Structural analysis on the material organization of glycosaminoglycans in developing endocardial cushions. Dev. Biol. 62: 292–316.
Matsumoto, K., Horikoshi, M., Rikimaru, K. and Enomoto, S. (1989) A study of an in vitro model of squamous cell carcinoma. J. Oral. Pathol. Med. 18: 498–501.
McNeal, J.E. (1984) Anatomy of the prostate and morphogenesis of BPH: In: A.B. Kimbal, K. Buhl and H.C. Carter (eds): New Approaches to the Study of Benign Prostatic Hyperplasia. A.R. Liss, Inc., New York, pp 27–53.
Mintz, B. and Illmensee, K. (1975) Normal genetically mosaic mice produced from malignant teratorcarcinoma cells. Proc. Natl. Acad. Sci. USA 72: 3585–3589.
Mukaida, H., Hirabayashi, N., Hirai, T., Iwata, T., Saeki, S. and Toge, T. (1991) Significance of freshly cultured fibroblasts from different tissues in promoting cancer cell growth. Int. J. Cancer 48: 423–427.
Nakajima, M. and Chop, A. (1991) Tumor invasion and extracellular marix degradative enzymes: regulation of activity of organ factors. Seminars Cancer Biol. 2: 115–127.
Nakano, S. and Ts’O, P.O. (1981) Cellular differentiation and neoplasia: characterization of subpopulations of cells that have neoplasia related growth properties in Syrian hamster embryo cell cultures. Proc. Natl. Acad. Sci. USA 78: 4995–4999.
Nathan, C. and Sporn, M. (1991) Cytokines in context. J. Cell Biol. 113: 981–986.
Neugut, A.I., Sherr, D., Robinson, E., Murray, T. and Nieves, J. (1992) Differences between first and second primary lung cancer. Cancer Epidemiol. Biomarkers 1: 109–112.
Nielsen, M., Thomsen, J.L., Primdahl, S., Dyreborg, U. and Andersen, J.A. (1987) Breast flcancer and atypia among young and middle-aged women. Br. J. Cancer 56: 814–881.9.
Nicolo, G., Salvi, S., Oliveri, G., Borsi, L., Castellani, P. and Zardi, L. (1990) Expression of tenascin and the ED-B containing oncofetal fibronectin isoform in human cancer. Cell. Differ. Dev. 32: 401–408.
Nohammer, G., Bajardi, F., Benedetto, C., Kresbach, H., Rojanapo, W. and Schauenstein, E. (1989) Histophotometric quantification of the field effect and the extended field effect of tumors. Free Rad. Res. Commun. 7: 129–137.
Ogden, G.R., Lane, E.B., Hopwood, D.V. and Chisholm, D.M. (1993) Evidence for field change in oral cancer based on cytokeratin expression. Br. J. Cancer 67: 1324–1330.
Ottman, R., King, M.C., Pike, M.C. and Henderson, B.E. (1983) Practical guide for estimating risk for familial breast cancer. Lancet ii: 556–558.
Picard, O., Rolland, Y. and Poupon, M.F. (1986) Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation and metastasis. Cancer Res. 46: 3290–3294.
Picardo, M., Schor, S.L., Grey, A.M., Howell, A., Laidlow, I., Redford, J. and Schor, A.M. (1991) Migration stimulating activity in serum of breast cancer patients. Lancet 337: 130–133.
Picardo, M., Grey, A.M., McGurk, M., Ellis, I. and Schor, S.L. (1992) Identification of migration stimulating factor in wound fluid. Exp. Mol. Path. 57: 8–21.
Pitot, H.C. and Cambell, H.A. (1987) An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat. Environ. Health Perspect. 76: 49–56.
Rosen, E.M. and Goldberg, I.D. (1989) Protein factors which regulate cell motility. In Vitro 25: 1079–1087.
Rubin, H. (1985) Cancer as a dynamic developmental disorder. Cancer Res. 45: 2935–2942.
Sappino, A.P., Schurch, W. and Gabbiani, G. (1990) Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab. Invest. 63: 144–161.
Schor, S.L. (1980) Cell proliferation and migration within three-dimensional collagen gels. J. Cell Sci. 41: 159–175.
Schor, S.L., Schor, A.M., Durning, P. and Rushton, G. (1985a) Skin fibroblasts obtained from cancer patients display foetal-like migratory behaviour on collagen gels. J. Cell Sci. 73: 235–244.
Schor, S.L., Schor, A.M., Rushton, G. and Smith, L. (1985b) Adult, foetal, and transformed fibroblasts display different migratory phenotypes on collagen gels: Evidence for an isoformic transition during foetal development. J. Cell Sci. 73: 221–234.
Schor, S.L., Haggie, J., Durning, P., Howell, A., Sellwood, R.A.S. and Crowther, D. (1986) The occurrence of a foetal fibroblast phenotype in breast cancer. Int. J. Cancer 37: 831–836.
Schor, S.L. and Schor, A.M. (1987) Clonal heterogeneity in fibroblasts: implications for the control of epithelial-mesenchymal interactions. BioEssays 7: 200–204.
Schor, S.L., Schor, A.M., Howell, A. and Crowther, D. (1987) Hypothesis: persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease. Exp. Cell Biol. 55: 11–17.
Schor, S.L., Schor, A.M. and Rushton, G. (1988a) Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. J. Cell Sci. 90: 401–407.
Schor, S.L., Schor, A.M., Grey, A.M. and Rushton, G. (1988b) Fetal and cancer patient fibroblasts produce an autocrine migration stimulating factor not made by normal adult cells. J. Cell Sci. 90: 391–399.
Schor, S.L., Schor, A.M., Grey, A.M., Chen, J., Rushton, G. and Ellis, I. (1989) Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic acid synthesis. In Vitro 25: 737–746.
Schor, S.L., Grey, A.M., Ellis, I., Schor, A.M., Coles, B. and Murphy, R. (1993) Migration stimulating factor: its structural homology to the gelatin-binding domain of fibronectin, mode of action and possible function in health and disease. In: G. Evans, C. Wigley and R. Warn (eds): Cell Behaviour: Adhesion and Motility. S.E.B. Symposium, No. 47, pp. 235–251.
Schor, S.L. (1994) Cytokine control of cell motility: modulation and mediation by the extracellular matrix. Prog. Growth Factor Res. 5: 223–248.
Schor, A.M., Rushton, G., Ferguson, J.E., Howell, A., Redford, J. and Schor, S.L. (1994) Phenotypic heterogeneity in breast fibroblasts: functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma. Int. J. Cancer. 59: 25–32.
Slaughter, D.P., Southwick, H.W. and Smejkal, W. (1953) Field cancerization in oral stratified squamous epithelium. Cancer 6: 963–968.
Sloan, P., Schor, S.L. and Lopes, V. (1990) Immunohistochemical study of the heterogeneity of tenascin distribution within the oral mucosa of the mouse. Archs. oral Biol. 35: 67–70.
Steeg, P. (1991) Genetic control of the metastatic phenotype. Seminars Cancer Cell Biol. 2: 105–110.
Stoker, A.W., Hatier, C. and Bissell, M.J. (1990) The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia. J. Cell Biol. 111: 217–228.
Svendsen, L.B., Thorup, J., Larson, J.K., Norgard, T., Willumsen, H. and Hansen, O.H. (1989) Association between tumor DNA aneuploidy and in vitro tetraploidy of skin fibroblasts in patients with colorectal neoplasms. Scand. J. Gastroenterol. 24: 755–760.
Tanaka, H., Mori, Y., Ishii, H. and Akedo, H. (1988) Enhancement of metastatic capacity of fibroblast-tumor cell interaction in mice. Cancer Res. 48: 1456–1459.
Thielmann, H.W., Edler, L., Burkhardt, M.R. and Jung, E.G. (1987) DNA repair synthesis in fibroblast strains from patients with actinic keratosis, squamous cell carcinoma, basal cell carcinoma, or malignant melanoma after treatment with ultraviolet light, N-acetoxy-2-acetyl-aminofluorene, methyl methanesulfonate and N-methyl-N-nitrosurea. J. Cancer Res. Clin. Oncol. 113: 171–186.
Toole, B.P. and Trelstad, R.L. (1971) Hyaluronate production and removal during corneal development in the chick. Dev. Biol. 26: 28–35.
Toole, B.P., Biswas, C. and Gross, J. (1979) Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc. Natl. Acad. Sci. USA 76: 6299–6303.
Turley, E.A. and Torrance, J. (1984) Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Expl. Cell Res. 161: 17–28.
Wynford-Thomas, D., Smith, P. and Williams, E.D. (1986) Prolongation of fibroblast lifespan associated with epithelial rat tumor development. Cancer Res. 46: 3125–3127.
Zetter, B.R. and Brightman, S.E. (1990) Cell motility and the extracellular matrix. Curr. Opin. Cell Biol. 2: 850–856.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Birkhäuser Verlag
About this chapter
Cite this chapter
Schor, S.L. (1995). Fibroblast subpopulations as accelerators of tumor progression: The role of migration stimulating factor. In: Goldberg, I.D., Rosen, E.M. (eds) Epithelial-Mesenchymal Interactions in Cancer. Experientia Supplementum, vol 74. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-9070-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-0348-9070-0_14
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-9893-5
Online ISBN: 978-3-0348-9070-0
eBook Packages: Springer Book Archive